Scimago Journal & Country Rank

Theranosticsopen access

Country Canada  - SIR icon SIR Ranking of Canada
80
H Index
Subject Area and CategoryMedicine
Medicine (miscellaneous)

Pharmacology, Toxicology and Pharmaceutics
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
PublisherIvyspring International Publisher
Publication typeJournals
ISSN18387640
Coverage2012-2020
Scope The aim of Theranostics is to provide a forum for the exchange of clinical and scientific information for the diagnostic and therapeutic molecular and nano medicine community and allied professions involved in the efforts of integrating molecular imaging and molecular therapy. Theranostics is a multidisciplinary journal that publishes innovative and original research articles reflecting fields of in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensor, nanobiosensor and bioelectronics, system biology and translational medicine, point-of-care and personalized medicine. A broad spectrum of biomedical research that can be applied to future theranostic applications is encouraged. In addition to primary research, Theranostics also publishes reviews, news, and commentary to understand and bridge the gap among the laboratory, clinic, and biotechnology industries. Papers in the journal are rigorously peer-reviewed.

Homepage

How to publish in this journal

Contact

Join the conversation about this journal
Quartiles

The set of journals have been ranked according to their SJR and divided into four equal groups, four quartiles. Q1 (green) comprises the quarter of the journals with the highest values, Q2 (yellow) the second highest values, Q3 (orange) the third highest values and Q4 (red) the lowest values.

CategoryYearQuartile
Medicine (miscellaneous)2013Q1
Medicine (miscellaneous)2014Q1
Medicine (miscellaneous)2015Q1
Medicine (miscellaneous)2016Q1
Medicine (miscellaneous)2017Q1
Medicine (miscellaneous)2018Q1
Medicine (miscellaneous)2019Q1
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2013Q1
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2014Q1
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2015Q1
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2016Q1
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2017Q1
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2018Q1
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)2019Q1
SJR

The SJR is a size-independent prestige indicator that ranks journals by their 'average prestige per article'. It is based on the idea that 'all citations are not created equal'. SJR is a measure of scientific influence of journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from It measures the scientific influence of the average article in a journal, it expresses how central to the global scientific discussion an average article of the journal is.

YearSJR
20131.560
20141.955
20152.586
20162.375
20172.515
20182.176
20192.348
Citations per document

This indicator counts the number of citations received by documents from a journal and divides them by the total number of documents published in that journal. The chart shows the evolution of the average number of times documents published in a journal in the past two, three and four years have been cited in the current year. The two years line is equivalent to journal impact factor ™ (Thomson Reuters) metric.

Cites per documentYearValue
Cites / Doc. (4 years)20120.000
Cites / Doc. (4 years)20138.427
Cites / Doc. (4 years)20148.945
Cites / Doc. (4 years)20159.986
Cites / Doc. (4 years)201610.222
Cites / Doc. (4 years)20179.610
Cites / Doc. (4 years)20188.993
Cites / Doc. (4 years)20199.259
Cites / Doc. (3 years)20120.000
Cites / Doc. (3 years)20138.427
Cites / Doc. (3 years)20148.945
Cites / Doc. (3 years)20159.986
Cites / Doc. (3 years)20169.979
Cites / Doc. (3 years)20179.577
Cites / Doc. (3 years)20188.683
Cites / Doc. (3 years)20199.175
Cites / Doc. (2 years)20120.000
Cites / Doc. (2 years)20138.427
Cites / Doc. (2 years)20148.945
Cites / Doc. (2 years)20159.786
Cites / Doc. (2 years)20169.865
Cites / Doc. (2 years)20179.129
Cites / Doc. (2 years)20188.364
Cites / Doc. (2 years)20198.698
Total Cites 
Self-Cites

Evolution of the total number of citations and journal's self-citations received by a journal's published documents during the three previous years.
Journal Self-citation is defined as the number of citation from a journal citing article to articles published by the same journal.

CitesYearValue
Self Cites20120
Self Cites201362
Self Cites2014103
Self Cites2015135
Self Cites2016176
Self Cites2017251
Self Cites2018347
Self Cites2019460
Total Cites20120
Total Cites2013809
Total Cites20141619
Total Cites20152776
Total Cites20162914
Total Cites20173754
Total Cites20185609
Total Cites20198909
External Cites per Doc 
Cites per Doc

Evolution of the number of total citation per document and external citation per document (i.e. journal self-citations removed) received by a journal's published documents during the three previous years. External citations are calculated by subtracting the number of self-citations from the total number of citations received by the journal’s documents.

CitesYearValue
External Cites per document20120
External Cites per document20137.781
External Cites per document20148.376
External Cites per document20159.500
External Cites per document20169.377
External Cites per document20178.936
External Cites per document20188.146
External Cites per document20198.701
Cites per document20120.000
Cites per document20138.427
Cites per document20148.945
Cites per document20159.986
Cites per document20169.979
Cites per document20179.577
Cites per document20188.683
Cites per document20199.175
% International Collaboration

International Collaboration accounts for the articles that have been produced by researchers from several countries. The chart shows the ratio of a journal's documents signed by researchers from more than one country; that is including more than one country address.

YearInternational Collaboration
201219.81
201331.58
201438.78
201540.91
201634.90
201734.43
201838.19
201933.39
Citable documents 
Non-citable documents

Not every article in a journal is considered primary research and therefore "citable", this chart shows the ratio of a journal's articles including substantial research (research articles, conference papers and reviews) in three year windows vs. those documents other than research articles, reviews and conference papers.

DocumentsYearValue
Non-citable documents20120
Non-citable documents201310
Non-citable documents201420
Non-citable documents201521
Non-citable documents201611
Non-citable documents20178
Non-citable documents201822
Non-citable documents201940
Citable documents20120
Citable documents201396
Citable documents2014181
Citable documents2015278
Citable documents2016292
Citable documents2017392
Citable documents2018646
Citable documents2019971
Cited documents 
Uncited documents

Ratio of a journal's items, grouped in three years windows, that have been cited at least once vs. those not cited during the following year.

DocumentsYearValue
Uncited documents20120
Uncited documents20134
Uncited documents201411
Uncited documents201515
Uncited documents201615
Uncited documents201714
Uncited documents201836
Uncited documents201939
Cited documents20120
Cited documents2013102
Cited documents2014190
Cited documents2015284
Cited documents2016288
Cited documents2017386
Cited documents2018632
Cited documents2019972
Scimago Journal & Country Rank
Show this widget in your own website

Just copy the code below and paste within your html code:
Loading comments...

Leave a comment

* Required

* Required

* Required

* Required

The users of Scimago Journal & Country Rank have the possibility to dialogue through comments linked to a specific journal. The purpose is to have a forum in which general doubts about the processes of publication in the journal, experiences and other issues derived from the publication of papers are resolved. For topics on particular articles, maintain the dialogue through the usual channels with your editor.

Developed by:
Scimago Lab
Powered by:
Powered by scopus

Follow us on @ScimagoJR

Scimago Lab, Copyright 2007-2020. Data Source: Scopus®